When should a mid‑luteal progesterone level be drawn in a 39‑year‑old woman post‑tubal reversal with shortened menstrual cycles?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 18, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mid-Luteal Progesterone Timing

Mid-luteal progesterone should be drawn 7 to 9 days after ovulation, which corresponds to approximately 5 to 10 days before the expected next menstrual period. 1

Optimal Timing Based on Ovulation Detection

  • The most accurate timing is 7–9 days after the thermogenic shift on basal body temperature monitoring or after a documented urinary luteinizing hormone (LH) surge. 1
  • This corresponds to the mid-luteal (ML) phase when progesterone secretion is most stable and representative of corpus luteum function. 2
  • In women with shortened menstrual cycles (such as your 39-year-old post-tubal reversal patient), careful tracking of ovulation is essential because the luteal phase timing shifts earlier in the calendar cycle. 1

Practical Application for Shortened Cycles

  • For a woman with a 24-day cycle: Draw progesterone on approximately cycle day 17–19 (assuming ovulation occurs around day 10–12).
  • For a woman with a 26-day cycle: Draw progesterone on approximately cycle day 19–21 (assuming ovulation occurs around day 12–14).
  • The key is counting backward 5–10 days from the expected next period, or forward 7–9 days from confirmed ovulation. 1

Interpretation Thresholds

  • A mid-luteal serum progesterone level ≥10 ng/mL is considered adequate and suggestive of ovulation with sufficient corpus luteum function. 1, 3
  • Levels <10 ng/mL are suggestive of luteal phase deficiency and warrant further evaluation. 1
  • For cycles resulting in live birth, 86–88% had progesterone values >10 ng/mL in the mid-luteal phase. 3

Special Consideration for Post-Tubal Reversal Patients

  • Women with prior tubal ligation or electrocoagulation have significantly lower mean mid-luteal progesterone levels (9.4 ± 4.7 ng/mL) compared to controls (17.4 ± 7.1 ng/mL). 4
  • In this population, 62% had progesterone levels <10 ng/mL versus only 17% in controls, suggesting a higher prevalence of luteal insufficiency. 4
  • This makes accurate timing and interpretation even more critical in your patient population. 4

Sampling Strategy for Borderline Results

  • If a single progesterone level is ≥10 ng/mL, this is sufficient to confirm adequate luteal function. 2
  • For results <10 ng/mL, consider obtaining three morning samples at hourly intervals during the mid-luteal phase to account for the pulsatile nature of progesterone secretion (7–14 pulses per 24 hours during ML phase). 2
  • The pulsatile amplitude of progesterone during the mid-luteal phase ranges from 4 to 40 ng/mL, which can affect single measurements. 2

Common Pitfalls to Avoid

  • Do not draw progesterone at a fixed cycle day without confirming ovulation timing—this is the most common error and leads to misinterpretation in women with variable cycle lengths. 1
  • Avoid drawing too early (before day 5 post-ovulation), as the corpus luteum is still developing and progesterone levels may not yet reflect peak function. 2
  • Avoid drawing too late (beyond day 12 post-ovulation), as progesterone levels begin declining in the late luteal phase. 2

Related Questions

Is a drop in estrone (e1g) levels on the 11th day after LH surge followed by an increase on the 12th day indicative of a luteal phase defect or possible pregnancy in a patient trying to conceive?
How can serum progesterone (Progesterone) levels indicate ovulation?
How does a luteal phase defect affect pregnancy and what treatment is recommended?
If a patient enters the luteal phase at 10 days post-ovulation (dpo), does that mean they are unlikely to be pregnant?
I have mid‑luteal cramps; what are the possible causes and recommended management?
What minor lifestyle modifications can a person with heart failure make to reduce shortness of breath, fatigue, and swelling?
What is the recommended workup and initial management for a patient with suspected hydronephrosis?
What are the typical clinical manifestations and symptoms of hydronephrosis?
What are the recommended calcium (1,000–1,200 mg/day) and vitamin D (800–1,000 IU/day) supplementation guidelines for post‑menopausal women and men aged 60 years or older, including dosing, dietary sources, and contraindications such as hypercalcemia, kidney stones, chronic kidney disease, and sarcoidosis?
What is the recommended management of herpes zoster, including antiviral therapy, analgesia, and prevention of post‑herpetic neuralgia, for immunocompetent and immunocompromised adults?
What are the appropriate next diagnostic and therapeutic steps for a patient with severe microcytic, hypochromic anemia (hemoglobin 7.3 g/dL, hematocrit 28%, mean corpuscular volume 66.7 fL, red cell distribution width 18.7%) and borderline low vitamin B12 (197 pg/mL) and borderline folate (4.5 ng/mL)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.